Patent · US Active

Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments

US9452227B2 · kind B2 · utility

22Cited by
97References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 24, 2009
Grant dateSep 27, 2016
Priority date
Expiry dateMar 22, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of anti-IL-6 antibodies or antibody fragments containing a specific epitopic specificity to treat conditions involving elevated Il-6. In some embodiments the anti-IL-6 antibodies contain specific CDRs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.